P Dufour

Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials

Eric Van Cutsem, Paulo M. Hoff, Peter Harper et al. · British Journal of Cancer · 2004 · 398 citations · Full text

Medicine, Oncology, Pharmacology +14

Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial

J Cassidy, J.-Y. Douillard, C.J. Twelves et al. · British Journal of Cancer · 2006 · 125 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17

Treatment of relapsed acute myeloid leukemia with idarubicin and intermediate-dose cytarabine.

Jean‐Luc Harousseau, Josy Reiffers, P Hurteloup et al. · Journal of Clinical Oncology · 1989 · 64 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

High dose melphalan and autologous marrow rescue in advanced epithelial ovarian carcinomas: a retrospective analysis of 35 patients treated in France.

Patrice Viens, D Maraninchi, Michel Legros et al. · PubMed · 1990 · 51 citations

Medicine, Gynecology, Oncology +14

Gemcitabine and protracted 5-FU for advanced pancreatic cancer. A phase II study.

Kurtz Je, F. Kohser, Sylvie Négrier et al. · PubMed · 2001 · 29 citations

Medicine, Oncology, Pharmacology +17